Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conversion of Pramipexole to Ropinirole CR in Parkinson's Disease
NCT00275275Phase 3Completed
- Start
- Jan 2006
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ropinirole in Parkinson's disease (PD) (3 arms). Primary endpoint: Adverse Effects Experienced at Week 4. Started Jan 2006; status: completed.
02
Drugs
ropinirole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00275275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00275275.